Robert Karr
Joho Capital
Robert Karr iKang Healthcare Group Inc stake
total: 89
Joho Capital KANG trades
- Total transactions:
- 3
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 1
- Held since:
- 2015 Q2
- Held for:
- 2 quarters
- Latest activity:
- 2015 Q4
According to 2026 Q1 report, Robert Karr doesn't hold any iKang Healthcare Group Inc (KANG) shares. To date, the estimated cost basis is nearly $19.34 for "buy" trades and estimated average "sell" price is $14.8. Joho Capital first purchased KANG in 2015 Q2, initially acquiring about 2.82M shares. Since the initial investment in iKang Healthcare Group Inc (KANG), Joho Capital has made 2 more transactions.
When did Robert Karr sell iKang Healthcare Group Inc (KANG)?
Robert Karr sold off the entire iKang Healthcare Group Inc (KANG) position in 2015 Q4.
When did Robert Karr buy iKang Healthcare Group Inc (KANG)?
Robert Karr first invested in iKang Healthcare Group Inc (KANG) in 2015 Q2 at the reported quarter-end price of $19.34 per share.
What's the cost basis of Joho Capital's KANG stake?
The estimated cost basis for iKang Healthcare Group Inc (KANG) stake is around $19.34 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $19.34
- Weighted AVG sell price:
- $14.80
Robert Karr's historical trades in iKang Healthcare Group Inc
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.